Publication | Closed Access

Pharmacokinetics of Nadolol, a Beta‐Receptor Antagonist: Administration of Therapeutic Single‐ and Multiple‐Dosage Regimens to Hypertensive Patients

HypertensionPharmacokinetic ModelingCardiovascular DiseaseHypertensive PatientsMedicineAntihypertensive TherapyMultiple‐dosage RegimensCardiovascular PharmacologyClinical PharmacologyPharmacotherapyPharmacologyPharmacokineticsBeta‐receptor Antagonist